Effect of Exogenous Lactate on Neurocognitive in Brain Trauma
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Mild traumatic brain injury (TBI) is the most common type of brain injury. Post-mild TBI disability could stem from cognitive, physical, psychological and social dysfunction which resulted in significant disability and unemployment. Long-term behavioral impairments which affected the individual's occupation, lifestyle, and family frequently occurred in individuals with mild to moderate brain injuries who physically fully recovered. In-vitro and in-vivo studies showed a better recovery of cognitive function after administration of exogenous lactate in traumatic brain injury. Therefore, this study is aimed to evaluate the effect of exogenous lactate infusion contained in hyperosmolar sodium lactate solution on cognitive function assessed by Mini Mental State Examination(MMSE)scale.
| Condition | Intervention |
|---|---|
|
Traumatic Brain Injury |
Drug: hyperosmolar sodium lactate |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Single Blind (Subject) Primary Purpose: Treatment |
| Official Title: | Effect of Exogenous Lactate Infusion on Neurocognitive Function of Patients With Mild Traumatic Brain Injury |
- Changes in neurocognitive function [ Time Frame: 24 hours, 30 days, and 90 days post surgery ] [ Designated as safety issue: Yes ]The investigators evaluate the changes in neurocognitive function at several time points (24 hours, 30 days, and 90 days post surgery) using Mini Mental State Examination (MMSE) score in both groups. Osmolality and sodium level are also recorded in order to confirm that hyperosmolar sodium lactate is safe for traumatic brain injury patients
| Enrollment: | 60 |
| Study Start Date: | March 2010 |
| Study Completion Date: | June 2010 |
| Primary Completion Date: | June 2010 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
No Intervention: Hyperosmolar sodium chloride
Patients in this group received intravenous infusion of hyperosmolar Sodium Chloride 3% at 1.5 ml.KgBW-1 within 15 minutes before neurosurgery
|
|
|
Experimental: Hyperosmolar sodium lactate
Patients in this group received intravenous infusion of hyperosmolar sodium lactate at 1.5 ml.KgBW-1 within 15 minutes before neurosurgery
|
Drug: hyperosmolar sodium lactate
Patients in this group received intravenous infusion of hyperosmolar sodium lactate at 1.5 ml.KgBW-1 within 15 minutes before neurosurgery
Other Name: Totilac
|
Detailed Description:
Mild traumatic brain injury (TBI) is the most common type of brain injury. Post-mild TBI disability could stem from cognitive, physical, psychological and social dysfunction which resulted in significant disability and unemployment. Cognitive impairment post traumatic brain injury is due to the disruption of brain vascular bed and microstructural damage. Currently, there is no specific therapy for individual with mild TBI. Neuropsychological assessment and early management immediately after mild traumatic brain injury have been shown to reduce long term cognitive disability. In-vitro and in-vivo studies showed a better recovery of cognitive function after administration of exogenous lactate in traumatic brain injury.
The role of lactate in cerebral energy metabolism has been investigated widely. The ability of lactate as the sole energy substrate to support synaptic function has been demonstrated by different studies. In many studies, lactate has been proven to be a preferred or even an obligatory substrate over glucose for aerobic energy production during the initial stage of recovery from cerebral ischemia or hypoxia for recovery from ATP-depleted synaptic function and exogenously supplied lactate can support the early recovery of synaptic function after hypoxia.
However, the clinical studies evaluated the effect of lactate administration on cognitive function in patients with mild traumatic brain injury are still limited. Therefore, we conduct a study to evaluate the effect of exogenous lactate infusion contained in hyperosmolar sodium lactate solution on cognitive function assessed by Mini Mental State Examination (MMSE) score evolution in mild traumatic brain injury compared with patients receiving hyperosmolar sodium chloride 3 % as a control group. MMSE score can be used as a tool to describe cognitive function.
Eligibility| Ages Eligible for Study: | 14 Years to 60 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Mild traumatic brain injury
- Glasgow Coma Scale (GCS) of 14-15
- Requires emergency neurosurgery procedures
- Physical status ASA I-II
- Onset of trauma < 9 hours
Exclusion Criteria:
- Multiple injury
- Pregnancy/lactation
- History of alcohol or barbiturate consumption prior to the injury
Contacts and Locations| Indonesia | |
| Hasan Sadikin Hospital | |
| Bandung, West Java, Indonesia, 40161 | |
| Principal Investigator: | Tatang Bisri, MD,PhD,Prof | Faculty of Medicine Universitas Padjadjaran - Dr. Hasan Sadikin Hospital Bandung |
More Information
No publications provided
| Responsible Party: | Universitas Padjadjaran |
| ClinicalTrials.gov Identifier: | NCT01455376 History of Changes |
| Other Study ID Numbers: | AN-001.2011 |
| Study First Received: | October 5, 2011 |
| Last Updated: | October 20, 2011 |
| Health Authority: | Indonesia: Departement Kesehatan (Department of Health) Indonesia: National Agency of Drug and Food Control |
Keywords provided by Universitas Padjadjaran:
|
brain injury cognitive function sodium lactate MMSE score |
Additional relevant MeSH terms:
|
Brain Injuries Brain Diseases Central Nervous System Diseases Nervous System Diseases |
Craniocerebral Trauma Trauma, Nervous System Wounds and Injuries |
ClinicalTrials.gov processed this record on May 23, 2013